Journal for ImmunoTherapy of Cancer (Nov 2021)

753 InhibigenTM administration promotes aberrant T cell responses in cancer but may be beneficial for amelioration of autoimmune disease

  • Jessica Flechtner,
  • Victoria DeVault,
  • Hubert Lam,
  • Julie Arnold,
  • Hanna Starobinets,
  • Stephanie Rinaldi,
  • Charley Hubbard,
  • Osaruese Odeh,
  • Cindy Nguyen,
  • Laura Apolloni,
  • Dimitry Lineker

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.753
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.